ODAIA Newsroom

In The Medicine Maker, ODAIA’s Pete Harbin explains why diagnosis delays are the real “last mile” challenge for precision therapies, and how commercial data can help close the gap.

See how legacy sales models lag behind, and how ODAIA helps pharma unlock precision medicine’s true commercial potential.

ODAIA CEO Philip Poulidis joins Emerj’s AI in Business podcast to discuss how commercial teams can close the gap between brand strategy and real‑time execution. Listen to the podcast now.

This industry outlook explains how AI will automate the consulting layer and transform pharma commercial operations from static reports into real-time, self-learning systems.

In its feature on five AI solutions, MM+M features ODAIA’s platform as an AI-powered commercial intelligence layer that helps pharma teams predict HCP behavior and drive measurable ROI.

ODAIA CEO Philip Poulidis joins Healthcare Today's Life Sciences podcast to discuss how ODAIA's AI platform is tackling pharma's biggest bottlenecks.

BioSpace features ODAIA’s CEO on using AI to show commercial discipline in M&A.

Why legacy KPIs like email opens and click-through rates measure activity instead of impact—and how AI-powered attribution can shift pharma commercial teams from counting touches to driving real behavior change and improved patient outcomes.

This article spotlights pharmacists as essential partners who make AI clinically relevant, patient-focused, and impactful for the industry.

AI-powered, dynamic targeting is transforming pharma sales—helping teams break free from static cycles.

Pharma & Healthcare's AI Revolution is coming. Explore disruptions to watch for in 2025.

Learn how AI transforms pharma product launches by enabling smarter HCP targeting

Discover how Canadian health-tech startups are leveraging AI and digital tools to support and improve the healthcare system.

Veeva and ODAIA team up to enhance AI-driven customer insights.

A fourth-year PharmD student, gained hands-on AI experience during a rotation at ODAIA.

Some of the biggest buzz at Veeva Commercial Summit involved artificial intelligence (AI) applications, an area that Veeva says the company will support with new APIs to make commercial data available to AI apps.

Explore this spotlight article on Peter Zhang

Discover LinkedIn’s sixth annual list of the top 15 startups in Canada as FinTech and AI startups dominate. AltaML, ODAIA, and SantuaryAI are also all notable Canadian AI startups that made this year’s list.

Using AI to help pharma companies deliver timely, data-driven insights and accelerate patient access to new therapies.

Toronto-based software startup ODAIA has secured $34 million CAD ($25 million USD) in Series B financing.

Explore why executives at Canadian tech companies are looking to the U.S. for opportunities‍.

Toronto-based ODAIAhas raised $13.8 million in Series A funding led by Flint Capital. The platform combines data analysis, process mining and AI to offer predictive analytics to pharmaceutical and life sciences commercial teams. The funding round comes as the company doubled the size of its team over the past year.

ODAIA aims to solve “a key problem in a very big industry” — how to derive actionable, real-time commercial insights from pharmaceutical sector data.

Using artificial intelligence (AI), pharmaceutical sales platform ODAIA is attempting to change the way pharma sales reps approach their work.